Priser
Platform
Blog
Om os
Download
Shenzhen Neptunus Interlong Bio-Technique Co
Shenzhen Neptunus Interlong Bio-Technique Co
Hong Kong Stock Exchange
0

Om

Shenzhen Neptunus Interlong Co., Ltd. is a prominent player in the pharmaceutical industry, focusing on the research, development, and production of high-quality healthcare products. This company primarily operates in the pharmaceutical manufacturing sector, providing a wide range of therapeutic solutions aimed at improving public health. Its product portfolio includes prescription drugs, over-the-counter medications, and health supplements designed to meet diverse healthcare needs. Based in Shenzhen, China, the company benefits from a strategic location that supports efficient distribution both domestically and internationally. As a significant figure in the pharmaceutical market, Shenzhen Neptunus Interlong is committed to innovation in drug research and development, leveraging advanced technology and robust supply chains to deliver safe and effective healthcare products. The company's operations not only advance medical science but also contribute to the development of the healthcare sector within China and beyond, underscoring its vital role in enhancing global health outcomes.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE CO MED ENDAVU: Køb Shenzhen Neptunus Interlong Bio-Technique Co ($8329) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Shenzhen Neptunus Interlong Bio-Technique Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker8329
Land
Hongkong
Antal medarbejdere1.382
Hjemmesideinterlong.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

0,16HKD
'25
Ex-udbytte-dato15. maj 2025
Udbytteafkast0%